Related Experiment Video
Updated: Jul 11, 2026
06:00
Portable Paper-Based Immunoassay Combined with Smartphone Application for Colorimetric and Quantitative Detection of Dengue NS1 Antigen
Published on: January 26, 2024
Towards a dengue vaccine: progress to date and remaining challenges
1Sanofi pasteur, 1541 Avenue Marcel Merieux, 69280 Marcy L'Etoile, France.
Comparative Immunology, Microbiology and Infectious Diseases
|September 25, 2007
Summary
Developing a Dengue virus vaccine is urgent due to rising cases. The main challenge is creating a safe vaccine that protects against all four serotypes without increasing disease severity.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Dengue virus incidence and geographical spread have significantly increased globally over the last 20 years.
- This rise in disease burden highlights the urgent need for effective Dengue virus vaccines.
Purpose of the Study:
- To review the current status of Dengue virus vaccine development.
- To discuss the challenges associated with the clinical progression of these vaccines.
Main Methods:
- Review of existing literature on Dengue virus vaccine strategies.
- Analysis of different vaccine platforms including live-attenuated, vectored, and inactivated/recombinant vaccines.
Main Results:
- Multiple vaccine strategies are under investigation globally.
- Key challenges include inducing a broad and durable immune response against all four Dengue virus serotypes.
Conclusions:
- Inducing simultaneous immunity against all four Dengue virus serotypes remains a significant hurdle.
- Avoiding enhanced risk of severe Dengue disease from incomplete or modified immune responses is critical for vaccine safety and efficacy.
Related Concept Videos
01:18Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:51Vaccinations
Overview